Hepatitis C (HCV) causes inflammation of the liver and is the most common form of viral hepatitis. Symptoms are often flu-like, but not severe, and many patients have no symptoms at all. HCV can be acute or chronic. There are treatments available for HCV. People born from 1945-1965 are five times more likely to have HCV and should be encouraged to get screened.
Through the HCV Clinical Service Line, AGA offers tools to help you become more efficient, understand quality standards and improve the process of care for patients.
educate your patients
AGA guidelines help you practice evidence-based medicine. Use the patient guideline summaries to help explain how guidelines impact patient care.
Digestive Disease Week® (DDW)
May 6, 2017
New HCV Treatments Work Well for Severe Liver Disease
March 21, 2017
HCV Genotype 1 No Longer a Treatment Bugbear
Feb. 17, 2017
Measure Your quality
Several mechanisms are available for capturing quality data related to the care of patients with HCV.
PCPI Measures for HCV (PDF)
Find funding opportunities for your Hepatitis C research from the AGA Research Foundation and other organizations.